| Name | Title | Contact Details |
|---|
Convenient Care Association is a Philadelphia, PA-based company in the Business Services sector.
Nitrogen Wealth, Inc. is a financial technology company that specializes in wealth management solutions aimed at enhancing communication between financial advisors and their clients. The company offers an all-in-one platform that simplifies client acquisition, retention, and portfolio management, allowing advisors to focus on business growth rather than administrative tasks. The platform includes several key components such as the Risk Center, which quantifies client risk tolerance using the proprietary Risk Number, and the Planning Center, which helps advisors model clients risk capacity and long-term success probabilities. Additionally, the Research Center provides deep portfolio analytics, while the Command Center offers firmwide controls for monitoring risk and growth. The Marketing Center supports client outreach efforts by utilizing the Risk Number as a conversation starter. Nitrogen Wealth serves financial advisors and wealth management firms primarily in the United States, emphasizing measurable growth and improved client engagement through its innovative tools and data-driven approach.
We know that drug development is both an art and a science. The work we do is incredibly technical, intentional, and specific, but there is an art to it - because we must leave room for creativity, innovation and spontaneity. Murals are paintings that transform overlooked or unused spaces - creating something impactful and meaningful. There remains many overlooked opportunities in cancer drug development. This is what inspires us. Our mission is simple, to create novel immunotherapies that can change patients lives so they can get back to what matters most - living. Mural Oncology is leveraging its industry-leading protein engineering platform to revolutionize cytokine-based immunotherapies for the treatment of cancer. Immunotherapies have been transformative for some people living with cancer, but unfortunately many patients still do not benefit - either because they are ineligible for treatment or they do not respond well to current therapies. We leverage our expertise in cytokine biology, immune cell modulation and our protein engineering capabilities to develop first and novel immunotherapies. Our goal is to deliver meaningful, clinical benefit across a wide range of cancers, including tumor types where immunotherapies have previously not been effective. Mural Oncology is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers. (NASDAQ: MURA)
BSI Management Search Consulting is a Nicholson, GA-based company in the Business Services sector.
Imprimatur is a Albuquerque, NM-based company in the Business Services sector.